Posted on February 2nd, 2016 by
In 2015, the increased use of Oncotype DX prostate cancer test promoted changes in treatment received, resulting in greater recommendations and adoption of active surveillance. Also noteworthy is the research devoted to best standard of treatment for all stages of prostate cancer.
CancerConnect News coverage of advances in the management of prostate cancer included the following key developments.
2015 Prostate Research News
2015 Oncotype DX News
LEARNING MORE ABOUT PROSTATE CANCER
Knowledge is power. Are you facing a new diagnosis, recurrence, living with metastatic disease, or supporting a loved one through their cancer journey?
Copyright © 2016 CancerConnect. All Rights Reserved.
You must be logged-in to the site to post a comment.